Seroprevalance of Bordetella pertussis antibodies among healthy adolescent girls in Edirne

Swiss Medical Weekly

Volumn 135, Issue 35-36, 2005, Pages 531-536

  Vatansever, Ülfet ^a   Çöplü, Nilay ^b   Öner, Nad ^a   Sönmez, Cemile ^b   Karasalihoǧlu, Serap ^a   Kurtoǧlu, Demet ^b   Esen, Berrin ^b   Ekuklu, Galip ^a  

^a TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b Parasitology Laboratory   (Turkey)

Author keywords

Adolescent girls; Immunity; Pertussis; Turkey

Indexed keywords

BACTERIUM ANTIBODY; HEMAGGLUTININ; PERTUSSIS TOXIN;

ADOLESCENT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL INFECTION; BLOOD SAMPLING; BORDETELLA PERTUSSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNIZATION; RURAL AREA; SCHOOL CHILD; SEROPREVALENCE; TURKEY (REPUBLIC); URBAN AREA; VACCINATION;

EID: 27644501311     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Mortimer EA. Pertussis. In Krugman's Infectious diseases children. Katz SL, Gershon AA, Hotez PJ (eds). 10th ed. Mosby-Year Book, Inc, Missouri. 1998, 335-49.
2. Pertussis Vaccines. WER 1999;74:137-44.http://www.who.int/ vaccines/en/pertussis.html.
3. Petersen JW. Cellular immunity in relation to pertussis vaccination and infection. Danish Medical Bulletin 1995;42:121-40.
4. General Directorate of Primary Health Care of Ministry of Health, Turkey. The Annual of Statistics 2001. Table 40. www.saglik.gov.tr/extras/ istatistikler/temel2001/103.html.
5. General Directorate of Primary Health Care of Ministry of Health, Turkey. The Annual of Statistics 2001. Table 38, www.saglik.gov.tr/extras/ istatistikler/temel2001/100.html.
6. Taranger J, Trollfors B, Bergfors E, et al. Mass vaccination of children with pertussis toxoid decreased incidence in both vaccinated and nonvaccinated persons. Clin Infect Dis 2001;33: 1004-9.
7. Arav-Boger R, Ashkenazi S, Gdalevich M, Cohen D, Danon YL. Seroprevalence of pertussis antibodies among adolescents in Israel. Isr Med Assoc J 2000;2:174-7.
8. Cattaneo L, Reed G, Haase D, Wills M, Edwards K. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years. J Infect Dis 1996;173:1256-9.
9. Campins-Marti M, Cheng HK, Forsyth K, et al. Recommendations are needed for adolescent and adult pertussis immunisation: Rationale and strategies for considerations. Vaccine 2002;20:641-6.
10. 2000 Turkey Census of Population. State Institute of Statistics Prime Ministry Republic of Turkey, Printing Division, Ankara, 2002.
11. Epi info (computer program). Revision 1. Atlanta: Centers for Disease Control and Prevention; 2002.
12. Ministry of Health of Turkey: National epidemiological surveillance of vaccine preventable diseases based on laboratory data. Turkish Bull Hyg Exp Biol 2001;58(Suppl. 1).
13. Corbeira PG, Dal Ra R, Aguilar L, Garcia-de-Lomas J. Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study. Vaccine 2000;18:2173-6.
14. Dominguez A, Vidal J, Plans P, Salleras L. The seroepidemilogy of B.pertussis infection in Catalonia, Spain. Epidemiol Infect 2001;126:205-10.
15. Finney DJ. Statistical Method in Biological Assay. Charles Griffin Co. Ltd., London, 1987.
16. Relyveld E, Oata NH, Nuet M, Gupta RK. Determination of antibodies to pertussis toxin in working reference preperations of anti-pertussis sera from various national control laboratories. Biologicals 1992:20:67-71.
17. Immunological basis for immunization. Module 4: Pertussis WHO/EPI/GEN/98.14.
18. Konda T, Kamachi K, Iwaki M, Matsunaga Y. Distribution of pertussis antibodies among different age groups in Japan. Vaccine 2002;20:1711-7.
19. Giammanco A, Chiarini A, Maple PAC, et al. European Ser-Epidemiology Network: Standardisation of the assay results for pertussis. Vaccine 2003,22:112-20.
20. de Malker HE, Versteegh FGA, Conyn-van Spaendonck MAE, et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 2000;38:800-6.
21. Healy CM, Munoz FM, Rench MA, Halasa NB, Edwards KM, Baker CJ. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis 2004;190:335-40.
22. Sato Y, Sato H, Kodama H, et al. An improved ELISA system for the measurement of IgG antibodies against pertussis toxin (PT) and filamentous hemagglutinin (FHA) in human sera. Develop Biol Standart 1990;73:167-74.
23. Kuno-Sakai H, Kimura M, Ohta K, et al. A simple and sensitive ELISA of antibodies to pertussis antigens. Vaccine 1992;10: 350-3.
24. Van Rie A, Hethcote HW. Adolescent and adult pertussis vaccination: computer simulations of five new strategies. Vaccine 2004;22:3154-65.
25. Edwards KM. Pertussis: an importanat target for maternal immunization. Vaccine 2003;21:3483-6.
26. Wielen MV, Damme PV, Herck KV, Schlegel-Haueter S, Siegrist CA. Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium). Vaccine 2003;21:2412-7.
27. Buydner PGV, Owen D, Vurdien JE, Andrews NJ, Matthews RC, Miller E. Bordetella pertussis surveillance in England and Wales: 1995-7. Epidemiol Infect 1999;123:403-11.